Trypanosoma cruzi evades the complement system as an efficient strategy to survive in the mammalian host: the specific roles of host/parasite molecules and …

G Ramírez-Toloza, A Ferreira - Frontiers in microbiology, 2017 - frontiersin.org
American Trypanosomiasis is an important neglected reemerging tropical parasitism,
infecting about 8 million people worldwide. Its agent, Trypanosoma cruzi, exhibits multiple …

Trypanosoma cruzi, Chagas disease and cancer: putting together the pieces of a complex puzzle

CD Kaufman, C Farré, L Biscari, AR Pérez… - Frontiers in Cell and …, 2023 - frontiersin.org
Considering the extensive and widespread impact on individuals, cancer can presently be
categorized as a pandemic. In many instances, the development of tumors has been linked …

The interactions of parasite calreticulin with initial complement components: consequences in immunity and virulence

G Ramírez-Toloza, L Aguilar-Guzmán, C Valck… - Frontiers in …, 2020 - frontiersin.org
Because of its capacity to increase a physiologic inflammatory response, to stimulate
phagocytosis, to promote cell lysis and to enhance pathogen immunogenicity, the …

Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System?

G Ramírez-Toloza, L Aguilar-Guzmán, C Valck… - Frontiers in …, 2021 - frontiersin.org
Chagas' disease is a zoonotic parasitic ailment now affecting more than 6 million people,
mainly in Latin America. Its agent, the protozoan Trypanosoma cruzi, is primarily transmitted …

Cancer and Trypanosoma cruzi: Tumor induction or protection?

PIR Franco, JR do Carmo Neto, MP Miguel… - Biochimie, 2023 - Elsevier
Trypanosoma cruzi causes Chagas disease, a neglected disease that can be divided,
overall, into acute and chronic phases. Understanding the mechanisms underlying its …

Trypanosoma cruzi calreticulin: immune evasion, infectivity, and tumorigenesis

G Ramírez-Toloza, E Sosoniuk-Roche, C Valck… - Trends in …, 2020 - cell.com
To successfully infect, Trypanosoma cruzi evades and modulates the host immune
response. T. cruzi calreticulin (TcCalr) is a multifunctional, endoplasmic reticulum (ER) …

Extracellular Trypanosoma cruzi calreticulin in the host–parasite interplay

G Ramírez, C Valck, VP Ferreira, N López… - Trends in …, 2011 - cell.com
Calreticulin (CRT) from vertebrates is a calcium-binding protein present mainly in the
endoplasmic reticulum (ER). There, it directs the conformation of proteins and controls …

Roles of Trypanosoma cruzi calreticulin in parasite–host interactions and in tumor growth

G Ramírez, C Valck, L Aguilar, U Kemmerling… - Molecular …, 2012 - Elsevier
In Latin America, there are about 10–12 million people infected with Trypanosoma cruzi, the
agent of Chagas' disease, one of the most important neglected tropical parasitism …

Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?

G Ramírez-Toloza, P Abello, A Ferreira - Frontiers in immunology, 2016 - frontiersin.org
Eight to 10 million people in 21 endemic countries are infected with Trypanosoma cruzi.
However, only 30% of those infected develop symptoms of Chagas' disease, a chronic …

In vitro treatment of a murine mammary adenocarcinoma cell line with recombinant Trypanosoma cruzi calreticulin promotes immunogenicity and phagocytosis

E Sosoniuk-Roche, P Cruz, I Maldonado, L Duaso… - Molecular …, 2020 - Elsevier
American Trypanosomiasis, a parasitic disease produced by Trypanosoma cruzi (T. cruzi),
endemic in Latin America, infects about 6 million people. During the chronic stage of the …